z-logo
Premium
Translational Medicine 2.0: From Clinical Diagnosis–Based to Molecular‐Targeted Therapies in the Era of Globalization
Author(s) -
Albani S,
Colomb J,
Prakken B
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.60
Subject(s) - translational medicine , clinical pharmacology , translational research , outcome (game theory) , clinical practice , field (mathematics) , medicine , engineering ethics , data science , pharmacology , computer science , family medicine , pathology , engineering , economics , mathematical economics , mathematics , pure mathematics
Translational medicine encompasses the itinerary from the conception of an idea to its implementation in the diagnosis, prognosis, and treatment of human diseases. It cannot be identified as a stand‐alone field; rather, it comprises a fragmented patchwork of activities, competencies, and knowledge distributed along diverse and often disparate disciplines. In standard practice, the success of a translational project is often less dependent on the validity of the original idea than on the outcome of the combination of several stochastic events. Clinical Pharmacology & Therapeutics (2010) 87 6, 642–645. doi: 10.1038/clpt.2010.60

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom